SRF
IMUX icon

Silver Rock Financial’s Immunic IMUX Stock Holding History

Silver Rock Financial’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-478
Closed -$1.73M – 5
2016
Q1 		$1.73M Sell
478
-12
-2% -$41.7K 1.76% 15
2015
Q4 		$2.26M Buy
+490
New +$1.6M 1.86% 16

Other funds holding IMUX

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Silver Rock Financial's IMUX Position: Q2 2016 in Review

Silver Rock Financial sold out of Immunic (IMUX) in Q2 2016, closing a stake of 478 shares — an estimated $1.73M sold.

Silver Rock Financial first reported a position in IMUX in Q4 2015 and held it in 2 quarters. The position peaked at $2.26M in Q4 2015. 54 funds tracked by Wall St. Rank hold IMUX as of Q2 2016.

  • Silver Rock Financial reported no remaining Immunic position as of Q2 2016 after selling out during the quarter.
  • Silver Rock Financial sold 478 Immunic shares in Q2 2016, an estimated $1.73M.
  • Silver Rock Financial first reported a position in Immunic in Q4 2015 and held it in 2 quarters.
  • Silver Rock Financial's Immunic position peaked at $2.26M in Q4 2015.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q2 2016.

Based on Silver Rock Financial's 13F filing for Q2 2016.